KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in IntangiblesChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Exchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares IssuedShares RepurchasedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Idexx Laboratories (IDXX) Gains from Sales and Divestitures (2016 - 2017)

Idexx Laboratories has reported Gains from Sales and Divestitures over the past 7 years, most recently at $155000.0 for Q4 2017.

  • For Q4 2017, Gains from Sales and Divestitures fell 8.82% year-over-year to $155000.0; the TTM value through Dec 2017 reached $155000.0, down 8.82%, while the annual FY2017 figure was $155000.0, 8.82% down from the prior year.
  • Gains from Sales and Divestitures for Q4 2017 was $155000.0 at Idexx Laboratories, down from $170000.0 in the prior quarter.
  • Over five years, Gains from Sales and Divestitures peaked at $196000.0 in Q4 2015 and troughed at $122000.0 in Q4 2014.
  • A 5-year average of $156400.0 and a median of $155000.0 in 2017 define the central range for Gains from Sales and Divestitures.
  • Biggest five-year swings in Gains from Sales and Divestitures: skyrocketed 60.66% in 2015 and later fell 13.27% in 2016.
  • Year by year, Gains from Sales and Divestitures stood at $139000.0 in 2013, then dropped by 12.23% to $122000.0 in 2014, then skyrocketed by 60.66% to $196000.0 in 2015, then decreased by 13.27% to $170000.0 in 2016, then fell by 8.82% to $155000.0 in 2017.
  • Business Quant data shows Gains from Sales and Divestitures for IDXX at $155000.0 in Q4 2017, $170000.0 in Q4 2016, and $196000.0 in Q4 2015.